ESSA Pharma Inc. Announces Appointment of New Director
Research and Markets: Anaplastic Large Cell Lymphoma (ALCL) Pipeline Review 2015 - 9 Companies & 12 Drug Profiles
Health-care stocks are on a tear as demand slowly returns.
The five biotech ETFs have very different portfolios with markedly different performance.
While we remain bullish on the sector, health-care growth depends on the economy.
With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.